Bioline

www.bioline.com

Bioline Reagents Limited
Unit 16 The Edge Business Centre
Humber Road
London
NW2 6EW

info.uk@bioline.com

+44 (0)20 8830 5300 Opt. 4

Overview

Bioline is an evolving international company, which develops, manufactures and markets a wide range of specialized bio-research reagents that simplify, accelerate and improve life sciences research. Our vision is to position Bioline at the forefront of human, animal and plant health through continuous innovation.

Founded in 1992 and headquartered in London, UK, Bioline is an evolving international company and our mission is to provide customers with a range of products which are fast and easy to use, guaranteed to work and developed by scientists who understand what our customers are trying to achieve so they can focus on their scientific goals. At Bioline, we constantly strive to improve and to deliver high quality products which are the result of our strong commitment and investment in science. Bioline, wholly owned by Meridian Bioscience Inc. (Nasdaq: VIVO), operates as one multi-cultural global team with strong values.

Bioline reagents are used by molecular biologists and other research scientists to perform test-assays and research in many fields from medical, biotechnology and marine biology to food and agriculture technology as well as forensic and environmental sciences, where life scientists have come to depend upon the outstanding quality and reliability of our reagents. As Bioline continues to evolve globally we aim to make the Bioline buying experience fast, easy and enjoyable for our customers. We strive to maintain close contact with our customers, key partners and collaborators to keep us at the forefront of new application areas and technologies providing feedback to our R&D groups and leading to new sustainable solutions for the bio-research reagents market.

We have developed and manufacture a portfolio of more than 300 reagents and kits, many of them proprietary, for molecular biology, cell analysis and nucleic acid and protein separation and purification. Since it was first established, Bioline has always responded quickly to meet the novel requirements of its industrial partners. With a proven track record for meeting the most stringent product and service requirements both quickly and efficiently, Bioline also offers a broad range of custom solutions, which can be tailored to meet your individual needs.

Bioline is an ISO 13485 certified company and one of the world’s few manufacturers of ultra-pure dNTPs, as well as a variety of enzymes and biochemicals. We have developed and manufacture a portfolio of more than 300 reagents and kits, many of them proprietary, for molecular biology, cell analysis and nucleic acid and protein separation and purification. Our core competencies and principal areas of activity in R&D and manufacturing encompass:

  • Fast qPCR & 2-Step RT-qPCR
  • Standard qPCR & 2-Step RT-qPCR
  • Fast 1-Step RT-qPCR
  • Real-Time PCR Genotyping
  • Real-Time PCR Instrumentation
  • Reverse Transcription for RT-qPCR
  • Standard PCR
  • Robust PCR
  • Long PCR
  • High-Fidelity PCR
  • Fast PCR
  • Core Reagents
  • cDNA Synthesis
  • Reverse Transcription
  • qPCR & RT-qPCR Extraction Controls
  • miRNA Analysis
  • Next Generation Sequencing
  • Direct PCR
  • RT-PCR
  • RNA Extraction
  • DNA Extraction
  • Cloning

Bioline understands the importance of adhering to the ISO 13485 quality standards when manufacturing, developing and supplying reagents. Our ISO certification confers the following benefits to our stakeholders: 

  • Complete confidence in Bioline
  • Reassurance of risk definition & management
  • Supply chain security
  • Materials traceability
  • Manufacturing consistency
  • Reproducible high standard of quality

Our adherence to the ISO quality standards not only confirms our commitment to being a reliable and technically competent partner, it also means we have greater understanding of our customers’ and partners’ requirements and are committed to further developing our industrial partnerships.

Articles